Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Flufenamic acid

Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca2+ channels, modulating non-selective cation channels (NSC), activating K+ channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.

Product Specifications

CAS Number

[530-78-9]

UNSPSC

12352005

Hazard Statement

H301, H315, H319

Target

AMPK; Calcium Channel; Chloride Channel; COX; Parasite; Potassium Channel

Type

Reference compound

Related Pathways

Anti-infection; Epigenetics; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling; PI3K/Akt/mTOR

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/Flufenamic-acid.html

Concentration

10mM

Purity

99.93

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(O)C1=CC=CC=C1NC2=CC=CC(C(F)(F)F)=C2

Molecular Formula

C14H10F3NO2

Molecular Weight

281.23

Precautions

H301, H315, H319

References & Citations

[1]Guinamard R, et al. Flufenamic acid as an ion channel modulator. Pharmacol Ther. 2013 May;138 (2) :272-84.|[2]Pongkorpsakol P, et al. Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation. Eur J Pharmacol. 2017 Mar 5;798:94-104.|[3]Pongkorpsakol P, et al. Cellular mechanisms underlying the inhibitory effect of flufenamic acid on chloride secretion in human intestinal epithelial cells. J Pharmacol Sci. 2017 Jun;134 (2) :93-100.|[4]Pobbati AV, et al. Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy. Structure. 2015;23 (11) :2076-2086.|[5]Fan Yang, et al. Topical Application of Butyl Flufenamate Ointment Promotes Cranial Defect Healing in Mice by Inducing BMP2 Secretion in Skin Mesenchymal Stem Cells. Cells. 2022 Nov 15;11 (22) :3620.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Isoform

L-type calcium channel

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)
MBS1148323-01 0.02 mg (E-Coli)

Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)

Ask
View Details
Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)
MBS1148323-02 0.1 mg (E-Coli)

Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)

Ask
View Details
Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)
MBS1148323-03 0.02 mg (Yeast)

Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)

Ask
View Details
Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)
MBS1148323-04 0.1 mg (Yeast)

Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)

Ask
View Details
Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)
MBS1148323-05 0.02 mg (Baculovirus)

Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)

Ask
View Details
Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)
MBS1148323-06 1 mg (E-Coli)

Recombinant Sulfolobus islandicus Chromatin protein Cren7 (creN7)

Ask
View Details